Pathology and genetics of meningiomas

Hussein Alahmadi1, Sidney E Croul

  • 1Department of Surgery, Division of Neurosurgery, University of Toronto, Toronto Western Hospital, Toronto, Ontario, Canada.

Insights

Meningiomas, common brain tumors, are classified by WHO grades. Genetic changes like chromosome 22 loss and radiation exposure influence their development and recurrence risk.

Area of Science:

  • Neuro-oncology
  • Tumor Pathology
  • Cancer Genetics

Background:

  • Meningiomas are the most common primary intracranial tumors, typically dural-based.
  • They are classified into WHO grades I, II, and III, with higher grades indicating increased recurrence and metastasis.
  • Fifteen histologic subtypes exist, further categorized by specific grading criteria.

Purpose of the Study:

  • To provide a mini-review of meningioma pathology and genetics.
  • To summarize current understanding of meningioma classification and risk factors.

Main Methods:

  • Review of existing literature on meningioma pathology and genetics.
  • Analysis of WHO classification system for meningiomas.
  • Summary of genetic abnormalities and environmental risk factors.

Main Results:

  • Loss of chromosome 22 (NF2 gene inactivation) is the most frequent genetic abnormality.
  • Other genetic factors include chromosomal losses at 1p, 14q, 9p21, and abnormalities of chromosomes 10 and 17q.
  • Ionizing radiation is the sole established environmental risk factor, linked to multiple tumors and higher recurrence rates.

Conclusions:

  • Meningioma grade, histology, genetics, and environmental factors are crucial for understanding tumor behavior.
  • Further research into genetic drivers and risk factors can inform diagnosis and treatment strategies.